Universe Pharmaceuticals INC (UPC) concluded trading on Thursday at a closing price of $0.16, with 4.63 million shares of worth about $0.74 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -99.71% during that period and on February 06, 2025 the price saw a loss of about -21.65%. Currently the company’s common shares owned by public are about 8.66M shares, out of which, 8.09M shares are available for trading.
Stock saw a price change of -61.67% in past 5 days and over the past one month there was a price change of -75.21%. Year-to-date (YTD), UPC shares are showing a performance of -73.61% which decreased to -99.45% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.18 but also hit the highest price of $64.80 during that period. The average intraday trading volume for Universe Pharmaceuticals INC shares is 2.86 million. The stock is currently trading -65.09% below its 20-day simple moving average (SMA20), while that difference is down -81.45% for SMA50 and it goes to -99.31% lower than SMA200.
Universe Pharmaceuticals INC (NASDAQ: UPC) currently have 8.66M outstanding shares and institutions hold larger chunk of about 8.92% of that.
The stock has a current market capitalization of $1.39M and its 3Y-monthly beta is at 1.44. It has posted earnings per share of -$5.10 in the same period. It has Quick Ratio of 1.44 while making debt-to-equity ratio of 0.24. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for UPC, volatility over the week remained 17.83% while standing at 11.65% over the month.
Analysts are in expectations that Universe Pharmaceuticals INC (UPC) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.
